148 related articles for article (PubMed ID: 15468687)
1. Development of a hydroxyapatite/collagen nanocomposite as a medical device.
Itoh S; Kikuchi M; Koyama Y; Takakuda K; Shinomiya K; Tanaka J
Cell Transplant; 2004; 13(4):451-61. PubMed ID: 15468687
[TBL] [Abstract][Full Text] [Related]
2. Implantation study of a novel hydroxyapatite/collagen (HAp/col) composite into weight-bearing sites of dogs.
Itoh S; Kikuchi M; Takakuda K; Nagaoka K; Koyama Y; Tanaka J; Shinomiya K
J Biomed Mater Res; 2002; 63(5):507-15. PubMed ID: 12209894
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel biomaterial, hydroxyapatite/collagen (HAp/Col) composite for medical use.
Itoh S; Kikuchi M; Koyama Y; Matumoto HN; Takakuda K; Shinomiya K; Tanaka J
Biomed Mater Eng; 2005; 15(1-2):29-41. PubMed ID: 15623928
[TBL] [Abstract][Full Text] [Related]
4. Influence of bone morphogenetic protein and proportion of hydroxyapatite on new bone formation in biphasic calcium phosphate graft: two pilot studies in animal bony defect model.
Yun PY; Kim YK; Jeong KI; Park JC; Choi YJ
J Craniomaxillofac Surg; 2014 Dec; 42(8):1909-17. PubMed ID: 25443868
[TBL] [Abstract][Full Text] [Related]
5. Development of an artificial vertebral body using a novel biomaterial, hydroxyapatite/collagen composite.
Itoh S; Kikuchi M; Koyama Y; Takakuda K; Shinomiya K; Tanaka J
Biomaterials; 2002 Oct; 23(19):3919-26. PubMed ID: 12162324
[TBL] [Abstract][Full Text] [Related]
6. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.
Barboza EP; Duarte ME; Geolás L; Sorensen RG; Riedel GE; Wikesjö UM
J Periodontol; 2000 Mar; 71(3):488-96. PubMed ID: 10776939
[TBL] [Abstract][Full Text] [Related]
7. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a compression resistant matrix for recombinant human bone morphogenetic protein-2.
Lu SX; Fiorini T; Lee J; Prasad HS; Buxton AN; Bisch FC; Dixon DR; Susin C; Wikesjö UM
J Clin Periodontol; 2013 Jul; 40(7):688-97. PubMed ID: 23627347
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants.
Cochran DL; Schenk R; Buser D; Wozney JM; Jones AA
J Periodontol; 1999 Feb; 70(2):139-50. PubMed ID: 10102551
[TBL] [Abstract][Full Text] [Related]
10. Use of porous hydroxyapatite graft containing recombinant human bone morphogenetic protein-2 for cervical fusion in a caprine model.
Takahashi T; Tominaga T; Watabe N; Yokobori AT; Sasada H; Yoshimoto T
J Neurosurg; 1999 Apr; 90(2 Suppl):224-30. PubMed ID: 10199252
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
[TBL] [Abstract][Full Text] [Related]
12. Effect of osteogenic protein 1/collagen composite combined with impacted allograft around hydroxyapatite-coated titanium alloy implants is moderate.
Lind M; Overgaard S; Jensen TB; Song Y; Goodman SB; Bünger C; Søballe K
J Biomed Mater Res; 2001 Apr; 55(1):89-95. PubMed ID: 11426402
[TBL] [Abstract][Full Text] [Related]
13. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
[TBL] [Abstract][Full Text] [Related]
14. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2.
Cochran DL; Nummikoski PV; Jones AA; Makins SR; Turek TJ; Buser D
Int J Oral Maxillofac Implants; 1997; 12(6):739-48. PubMed ID: 9425754
[TBL] [Abstract][Full Text] [Related]
15. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model.
Jones AA; Buser D; Schenk R; Wozney J; Cochran DL
J Periodontol; 2006 Jul; 77(7):1184-93. PubMed ID: 16805681
[TBL] [Abstract][Full Text] [Related]
16. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
[TBL] [Abstract][Full Text] [Related]
17. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
18. Effect of bone morphogenetic protein-2/hydroxyapatite on ankle fusion with bone defect in a rabbit model: a pilot study.
Dang LHN; Lee KB
J Orthop Surg Res; 2020 Aug; 15(1):366. PubMed ID: 32859231
[TBL] [Abstract][Full Text] [Related]
19. The biocompatibility and osteoconductive activity of a novel hydroxyapatite/collagen composite biomaterial, and its function as a carrier of rhBMP-2.
Itoh S; Kikuchi M; Takakuda K; Koyama Y; Matsumoto HN; Ichinose S; Tanaka J; Kawauchi T; Shinomiya K
J Biomed Mater Res; 2001 Mar; 54(3):445-53. PubMed ID: 11189053
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study.
Hunt DR; Jovanovic SA; Wikesjö UM; Wozney JM; Bernard GW
J Periodontol; 2001 May; 72(5):651-8. PubMed ID: 11394401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]